ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Hologic, Inc. ?
1
High Management Efficiency with a high ROE of 26.13%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.44 times
3
Poor long term growth as Net Sales has grown by an annual rate of -1.87% over the last 5 years
4
Flat results in Dec 25
- NET PROFIT(Q) Lowest at USD 181.98 MM
5
With ROE of 15.39%, it has a fair valuation with a 3.82 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 23.79%, its profits have risen by 3.1% ; the PEG ratio of the company is 5
6
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Hologic, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Hologic, Inc. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Hologic, Inc.
21.4%
0.06
25.61%
S&P 500
18.34%
0.98
19.26%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.87%
EBIT Growth (5y)
-12.34%
EBIT to Interest (avg)
14.25
Debt to EBITDA (avg)
0.44
Net Debt to Equity (avg)
0.19
Sales to Capital Employed (avg)
0.54
Tax Ratio
18.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
26.30%
ROE (avg)
26.13%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
3.82
EV to EBIT
20.70
EV to EBITDA
16.01
EV to Capital Employed
3.75
EV to Sales
4.90
PEG Ratio
5.04
Dividend Yield
NA
ROCE (Latest)
18.10%
ROE (Latest)
15.39%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 6.79 times
RAW MATERIAL COST(Y)
Fallen by 1.08% (YoY
-1What is not working for the Company
NET PROFIT(Q)
Lowest at USD 181.98 MM
Here's what is working for Hologic, Inc.
Debtors Turnover Ratio
Highest at 6.79 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by 1.08% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Hologic, Inc.
Net Profit
Lowest at USD 181.98 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
